Ruinan Tian

Statistics

Publications

Citations

185

H-Index

Active since

2022

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Tianjin Medical University

Ruinan Tian is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, molecular oncology, and breast cancer progression.

ORCID

Publications per year

2022–2023

Publications

Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling

Baoai Han, He Zhang, Ruinan Tian et al. · Theranostics · 2022 · 83 citations · Full text

Medicine, Cell Biology, Oncology +17

Fructose-Induced mTORC1 Activation Promotes Pancreatic Cancer Progression through Inhibition of Autophagy

Yanfen Cui, Jianfei Tian, Zhaosong Wang et al. · Cancer Research · 2023 · 35 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Fructose promotes angiogenesis by improving vascular endothelial cell function and upregulating VEGF expression in cancer cells

Yanfen Cui, Hui Liu, Zhaosong Wang et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 26 citations · Full text

Medicine, Nutritional Sciences, Oncology +17

RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin

Ruinan Tian, Jianfei Tian, Xiaoyan Zuo et al. · Cell Death and Disease · 2023 · 24 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy

Xiaoyan Zuo, Sixin Ren, He Zhang et al. · Journal of Translational Medicine · 2022 · 17 citations · Full text

Medicine, Cancer Biology, Oncology +13

1–5 of 5